Innovation Pharmaceuticals IPIX Stock
Innovation Pharmaceuticals Price Chart
Innovation Pharmaceuticals IPIX Financial and Trading Overview
| Innovation Pharmaceuticals stock price | 0.0005 USD |
| Previous Close | 0.0002 USD |
| Open | 0.01 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0007 - 0.01 USD |
| 52 Week Range | 0.0001 - 0.05 USD |
| Volume | 12.6K USD |
| Avg. Volume | 211.8K USD |
| Market Cap | 259.17K USD |
| Beta (5Y Monthly) | 161.431 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IPIX Valuation Measures
| Enterprise Value | 90.17K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.25 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.045 |
Trading Information
Innovation Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 161.431 |
| 52-Week Change | -28.57% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.00042 USD |
| 200-Day Moving Average | 0.0006075 USD |
IPIX Share Statistics
| Avg. Volume (3 month) | 211.8K USD |
| Avg. Daily Volume (10-Days) | 145.23K USD |
| Shares Outstanding | 514.01M |
| Float | 514.1M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2023 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | June 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.42% |
| Return on Equity (ttm) | -114.33% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1985000 USD |
| Net Income Avi to Common (ttm) | -2620000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 864K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 695K USD |
| Total Debt/Equity (mrq) | 59.81 USD |
| Current Ratio (mrq) | 0.186 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1992000 USD |
| Levered Free Cash Flow (ttm) | -986375 USD |
Profile of Innovation Pharmaceuticals
| Country | United States |
| State | MA |
| City | Wakefield |
| Address | 301 Edgewater Place |
| ZIP | 01880 |
| Phone | 978 921 4125 |
| Website | https://www.ipharminc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It offers Brilacidin, a immunomodulatory drug candidate with anti-inflammatory and antimicrobial therapeutic applications. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Q&A For Innovation Pharmaceuticals Stock
What is a current IPIX stock price?
Innovation Pharmaceuticals IPIX stock price today per share is 0.0005 USD.
How to purchase Innovation Pharmaceuticals stock?
You can buy IPIX shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Innovation Pharmaceuticals?
The stock symbol or ticker of Innovation Pharmaceuticals is IPIX.
Which industry does the Innovation Pharmaceuticals company belong to?
The Innovation Pharmaceuticals industry is Biotechnology.
How many shares does Innovation Pharmaceuticals have in circulation?
The max supply of Innovation Pharmaceuticals shares is 518.35M.
What is Innovation Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Innovation Pharmaceuticals PE Ratio is now.
What was Innovation Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Innovation Pharmaceuticals EPS is -0.02 USD over the trailing 12 months.
Which sector does the Innovation Pharmaceuticals company belong to?
The Innovation Pharmaceuticals sector is Healthcare.
